Class I Device-Makers Get Wiggle Room As US FDA Pushes UDI Compliance Date To 2020
Executive Summary
Manufacturers of low-risk class I products were given an extra two years to comply with FDA's Unique Device Identification requirements to give the agency and industry time to work through challenges posed by incorporating device identifiers into electronic health systems.
You may also be interested in...
US FDA Tweaks Direct Marking Rules In UDI Enforcement Delay
FDA’s latest update to Unique Device Identification compliance deadlines says the agency won’t enforce direct marking UDI rules for some existing devices if the UDI can be determined in other ways.
UDI Database Deadline Extended Again For Certain Combo Products
Following an extension for Unique Device Identifier requirements for low-risk devices earlier this summer, US FDA has pushed back a deadline to input UDI date into its GUDID database for combination products that go through the drug center. Manufacturers, however, are still required to implement UDIs labeling by Sept. 24.
US FDA Extends UDI Deadlines For Low-Risk Devices
The agency slowed down its effort to require the overwhelming majority of medical devices to adopt Unique Device Identifiers with a new guidance that would in delay full implementation of the UDI system for lower-risk devices.